AVALO THERAPEUTICS, INC. Number of Reporting Units
AVALO THERAPEUTICS, INC. (AVTX) reported Number of Reporting Units of 1 reportingUnit for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-23.
Financial Statements › Notes
us-gaap:NumberOfReportingUnits · last filed 2026-03-23
- AVALO THERAPEUTICS, INC. number of reporting units for fiscal 2022 was 1.00 reporting_unit, a 0.00% change from fiscal 2021.
- AVALO THERAPEUTICS, INC. number of reporting units for fiscal 2021 was 1.00 reporting_unit, a 0.00% change from fiscal 2020.
- AVALO THERAPEUTICS, INC. number of reporting units for fiscal 2020 was 1.00 reporting_unit, a 0.00% change from fiscal 2019.
- AVALO THERAPEUTICS, INC. number of reporting units for fiscal 2019 was 1.00 reporting_unit, a 0.00% change from fiscal 2018.
reporting_unit
| Period end | Number of Reporting Units 6 month | Number of Reporting Units 9 month | Number of Reporting Units 12 month |
|---|---|---|---|
| 2022-12-31 | 1.00 reporting_unit 10-K · filed 2023-03-29 | ||
| 2021-12-31 | 1.00 reporting_unit 10-K · filed 2022-03-02 | ||
| 2020-12-31 | 1.00 reporting_unit 10-K · filed 2021-03-08 | ||
| 2019-12-31 | 1.00 reporting_unit 10-K · filed 2020-03-11 | ||
| 2018-12-31 | 1.00 reporting_unit 10-K · filed 2019-03-18 | ||
| 2018-09-30 | 1.00 reporting_unit 10-Q · filed 2018-11-13 | ||
| 2018-06-30 | 1.00 reporting_unit 10-Q · filed 2018-08-09 |
reportingUnit
| Period end | Number of Reporting Units 12 month |
|---|---|
| 2025-12-31 | 1.00 reportingUnit 10-K · filed 2026-03-23 |
| 2024-12-31 | 1.00 reportingUnit 10-K · filed 2025-03-20 |
| 2023-12-31 | 1.00 reportingUnit 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |